Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | AGXT | P21549 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31059717 | 1.00 | TSHR (0.43) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL21440871 | 0.82 | RCE1 (0.48) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL7228724 | 0.82 | TSHR (0.44) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL11026537 | 0.81 | CA1 (0.38) | IDO1CA1CA2CA9SIGMAR1 | |
| SCHEMBL6239311 | 0.80 | SLC1A3 (0.47) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL6172748 | 0.80 | SLC1A3 (0.47) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL9250351 | 0.80 | RCE1 (0.45) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL4588952 | 0.80 | SLC1A3 (0.47) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL22882738 | 0.79 | RCE1 (0.46) | TSHRRCE1IDO1SLC1A3SLC1A2 | |
| SCHEMBL10618556 | 0.79 | RCE1 (0.46) | TSHRRCE1IDO1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815766-B2 | Process for double carbonylation of allyl ethers to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-11-14 | — | — | US | disclosed |
| US-9815766-B2 | Process for double carbonylation of allyl ethers to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-11-14 | — | — | US | disclosed |
| US-9815766-B2 | Process for double carbonylation of allyl ethers to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-11-14 | — | — | US | disclosed |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-8530452-B2 | Tricyclic boron compounds for antimicrobial therapy | MICURX PHARMACEUTICALS, INC. (KY) | 2013-09-10 | — | — | US | disclosed |
| US-20130165411-A1 | TRICYCLIC BORON COMPOUNDS FOR ANTIMICROBIAL THERAPY | MICURX PHARMACEUTICALS, INC. (KY) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165411-A1 | TRICYCLIC BORON COMPOUNDS FOR ANTIMICROBIAL THERAPY | TBCA, TBCB, BTD | TSHR 2173/4885RCE1 3940/4885IDO1 3821/4885 |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | CBR3, CBR1, EPOR | TSHR 256/4885RCE1 3746/4885IDO1 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.